THC Therapeutics Inc logo

THC Therapeutics Inc

NEW
OTCPK:THCT (USA)  
$ 0.00 0 (0%) 12:08 AM EST
At Loss
Market Cap:
$ 16.00K
Enterprise V:
$ 745.00K
Volume:
-
Avg Vol (2M):
9.59K
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
9.59K

Business Description

Description
THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset -259.67
Debt-to-Equity -0.19
Debt-to-EBITDA -1.49
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 0.02
9-Day RSI 1.08
14-Day RSI 5.36
6-1 Month Momentum % -9.09
12-1 Month Momentum % 900

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16.7
Shareholder Yield % 215.63

Profitability Rank

Name Current Vs Industry Vs History
ROA % -3769.74
ROIC % -17.64
3-Year ROIIC % 44800
Years of Profitability over Past 10-Year 1

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -1.51
EV-to-EBITDA -1.51
EV-to-FCF -15.85
Earnings Yield (Greenblatt) % -66.23
FCF Yield % -293.75

Financials

THCT's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:THCT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

THC Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.06
Beta 273.72
Volatility % 3612.52
14-Day RSI 5.36
14-Day ATR ($) 0.000083
20-Day SMA ($) 0.00131
12-1 Month Momentum % 900
52-Week Range ($) 0.0001 - 0.00785
Shares Outstanding (Mil) 40.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

THC Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

THC Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

THC Therapeutics Inc Frequently Asked Questions

What is THC Therapeutics Inc(THCT)'s stock price today?
The current price of THCT is $0.00. The 52 week high of THCT is $0.01 and 52 week low is $0.00.
When is next earnings date of THC Therapeutics Inc(THCT)?
The next earnings date of THC Therapeutics Inc(THCT) is .
Does THC Therapeutics Inc(THCT) pay dividends? If so, how much?
THC Therapeutics Inc(THCT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1